Noncardiogenic pulmonary edema following injection of methotrexate into the cerebrospinal fluid
- 1 September 1982
- Vol. 50 (5) , 866-868
- https://doi.org/10.1002/1097-0142(19820901)50:5<866::aid-cncr2820500510>3.0.co;2-6
Abstract
The most common pulmonary disorder induced by methotrexate is a gradually developing interstitial pneumonitis. The associated clinical manifestations include slowly progressive dyspnea and nonproductive cough, with extensive radiographic changes. One case has been reported following intrathecal methotrexate administration; the remainder occurred after either intravenous or oral therapy. We report two cases of rapidly developing respiratory distress following the administration of methotrexate into the cerebrospinal fluid. The clinical courses, radiologic findings, and, in one patient, the pathologic nature, are consistent with noncardiogenic pulmonary edema.This publication has 9 references indexed in Scilit:
- Cytotoxic drug-induced pulmonary disease: Update 1980The American Journal of Medicine, 1980
- PATHOGENESIS OF PULMONARY-EDEMA ASSOCIATED WITH THE ADULT RESPIRATORY-DISTRESS SYNDROME1979
- Pathogenesis of Neurogenic Pulmonary Edema1American Review of Respiratory Disease, 1978
- Anaphylactoid type reactions in two patients receiving high dose intravenous methotrexateCancer, 1977
- Noncardiogenic Pulmonary EdemaMedical Clinics of North America, 1977
- Methotrexate-induced sudden fatal pulmonary reactionCancer, 1977
- Methotrexate pneumonitis induced by intrathecal methotrexate therapy.A case report with pharmacokinetic dataCancer, 1976
- METHOTREXATE-INDUCED PNEUMONITISMedicine, 1976
- Shock Lung: A Disorder of the Central Nervous System?Hospital Practice, 1974